抽检视角下的药品网络销售ESG风险分析与对策建议

Analysis and Proposed Countermeasures on ESG Risks in Online Pharmacies from the Perspective of Drug Quality Sampling and Testing

关键词:  ESG风险管理框架  药品网络监管  优化策略

Key words:  ESG Risk Management Framework  Online Pharmacies Regulation  Optimization Strategies

摘要:

摘要：目的 基于ESG风险管理框架，从抽检视角，分析药品网络销售涉及的问题，为进一步优化药品网络监管策略提供参考。方法 基于国家药品抽检信息系统，分析2022年-2023年国家药品抽检网络抽检专项数据，梳理过程管理中遇到的有关问题。同时采用文献分析法，汇总收集药品网络抽检制度框架与网络销售现状。综合梳理与汇总结果，按照ESG风险管理框架进行风险分析，并制定应对监管建议与策略。结果 综合分析显示，药品网络销售供应链存在法规制度需进一步完善，配送体系质量不高，药学服务缺乏规范，追溯机制尚不健全，平台的监督管理责任需要强化等问题。结论 国家药品抽检专项能够挖掘药品网络销售供应链各环节的潜在风险，建议进一步完善法律法规，扩大抽查检验范围与品种覆盖面，督促引导健全药品追溯机制，加强线上药学服务管理，建立符合药品储运条件的绿色配送体系。

Abstract:

ABSTRACT: OBJECTIVE To analyze the issues involved in online drug sales from the perspective of sampling inspection based on the ESG risk management framework, and to provide a reference for further optimizing online drug supervision strategies. METHODS Based on the National Drug Sampling Information System, this study analyzed the special data of national drug sampling online inspections from 2022 to 2023, and sorted out the related issues encountered in the process management. Meanwhile, a literature analysis method was used to summarize the framework of the online drug sampling system and the current status of online sales. By integrating the sorting and summary results, a risk analysis was conducted according to the ESG risk management framework, and regulatory recommendations and strategies were formulated. RESULTS The comprehensive analysis revealed that the online pharmacies supply chain has issues such as the need for further improvement of regulatory systems, low quality of distribution systems, lack of standardized pharmaceutical services, an imperfect traceability mechanism, and a need to strengthen the supervision and management responsibilities of platforms. CONCLUSION The drug quality sampling and testing program can uncover potential risks at various stages of the online pharmacies supply chain. It is recommended to further improve laws and regulations, expand the scope of sampling inspections and the coverage of product categories, urge and guide the establishment of a sound drug traceability mechanism, strengthen the management of online pharmaceutical services, and establish a green distribution system that meets the conditions for drug storage and transportation.